| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/30/2026 | ±3.1% | -3.7% | under-priced |
| 11/05/2025 | ±2.1% | -1.4% | over-priced |
| 08/06/2025 | ±2.4% | -0.4% | over-priced |
| 05/05/2025 | ±2.5% | -0.3% | over-priced |
| 11/07/2024 | ±2.4% | +0.7% | over-priced |
| 08/08/2024 | ±5.9% | +7.2% | under-priced |
| 05/10/2024 | ±2.0% | +4.3% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $2.21 | $10.8B | $1.5B |
| Q1 FY2026 | $-0.28 | $7.4B | $-180M |
| Q4 FY2025 | $1.52 | $9.4B | $1.0B |
| Q3 FY2025 | $2.21 | $11.1B | $1.5B |
CRH Public Limited Company (CRH) reports in 114 days, with the next report estimated for 01/04/2027. Across the last 7 reports, options priced an average ±2.9% earnings move while the stock actually moved 2.6% on average — the market has been roughly fair on CRH's earnings risk. Fundamentals into the print: EPS up 13.9% year-over-year, revenue up 5.6%. QuantLogix's live 5-factor engine currently reads CRH as a underweight at 34/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →